drugset / Trial / NCT01459588

Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease

NCT01459588

Phase 3 Completed 315 enrolled Allergan
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will evaluate the safety, efficacy, and acceptability of an eye drop formulation in subjects with dry eye disease.

Timeline

Start
2011-10-01
Primary completion
2012-02-15
Completion
2012-02-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboxymethylcellulose Other / unclassified Topical

Indications